A recent study found that patients with carotid atheroma containing microplastics or nanoplastics had a four-fold increased risk of heart attack, stroke, or all-cause death compared to patients without plastic in their arteries.

Additionally, the researchers found that polyethylene was present in the atheroma of more than half of the 304 patients in the study, and polyvinyl chloride was present in 12.1% of patients.

Helio | Cardiology Today Editorial Board Larry B. Goldstein, MD, FAAN, FANA, FAHA; A person not involved in the study said it was “an important early study showing a link between… [microplastics and/or nanoplastics (MNPs)] However, it is unclear what can be done to prevent events associated with the “fairly ubiquitous” MNP.

It was top news in cardiology last week.

In other top news, the FDA approved an expanded label for Wegovy 2.4 mg (semaglutide, Novo Nordisk) for the prevention of cardiovascular events in overweight and obese patients. In making its decision, the FDA evaluated the results of the SELECT trial, which found that 6.5% of patients who took semaglutide experienced a major cardiovascular event, compared to 8% of patients who took a placebo. It turned out that he had experienced a cardiovascular event.

Read the top articles in cardiology below.

Tiny plastics in carotid artery plaque can lead to heart attacks, strokes, death

Among patients with asymptomatic carotid artery disease who underwent carotid endarterectomy, patients whose atheroma contained microplastics or nanoplastics had worse outcomes than those whose atheroma did not contain microplastics or nanoplastics. researchers reported. read more.

Semaglutide 2.4 mg was approved to prevent CV events in overweight patients. obesity

Novo Nordisk and the FDA announced the approval of a new indication for semaglutide 2.4 mg to reduce the risk of serious cardiovascular events in adults who are overweight or obese and have established cardiovascular disease. read more.

Sugary drink intake may predict risk of heart abnormalities rhythm

Adults who consume at least 2 liters of sugar-sweetened or artificially sweetened beverages per week develop atrial fibrillation during nearly 10 years of follow-up, independent of other traditional CV risk factors, data show There was a high possibility. read more.

Many American Indian teens and young adults suffer from dyslipidemia, an increase in heart disease danger

In a Native American cohort, more than 70% of youth and more than 50% of adolescents had dyslipidemia, and some had subclinical or clinical heart disease, according to new data from the Strong Heart Study. . read more.

FDA approves pediatric cardiac ultrasound enhancer patient

Lantheus Holdings announced that the FDA has approved a supplemental new drug application for perflutrene lipid microsphere injection to improve ultrasound images in pediatric patients with suboptimal echocardiograms. read more.